/Investor DB

Dolby Family Ventures — Full Portfolio

146 tracked investments · listed companies and verified rows first

Hyperfine Researchhyperfine.ioin𝕏NASDAQ: HYPR

Hyperfine develops diagnostic imaging and data solutions for patient care.

AI & Machine LearningDeep TechHealthtechMedical Devices

Jonathan Rothberg(Founder)Maria Sainz(President, Chief Executive Officer and Director)Brett Hale(Chief Administrative Officer, Chief Financial Officer, Treasurer and Corporate Secretary)Thomas Teisseyre(Chief Operating Officer)Jonathan M. Rothberg(Founder)

Co-investorsAltium CapitalColle Capital PartnersGV (Google Ventures)

Talkspacetalkspace.comin𝕏NASDAQ: TALK

Talkspace is an online mental health care platform that provides research-backed therapy and psychiatric services covered by insurance, allowing users to connect with licensed therapists and psychiatrists through text, audio, or video.

Digital HealthHealthtechMental Health

Oren Frank(Founder)inRoni Frank(Founder)inJon Cohen, M.D.inJon Cohen(Chief Executive Officer and Director)inShadi Catterina, MPHin

Co-investorsCompoundHDS CapitalNorwest Venture PartnersQumra CapitalRevolutionRunway Venture Partners+15 more

Vaxcytevaxcyte.comNASDAQ: PCVXSeries A · Jul 2015 · $22M

Vaxcyte is a clinical-stage biotechnology company developing vaccines to prevent or treat bacterial infectious diseases, including pneumococcal conjugate vaccine candidates.

BiotechHealthtech

Grant Pickering(Chief Executive Officer, Director and Co-Founder)inJeff Fairman(Vice President of Research and Co-Founder)

Co-investorsBioRock VenturesCTI Life Sciences Fund L.P.Foresite CapitalFrazier Life SciencesLongitude CapitalPivotal Life Sciences+3 more

AccuKnox Risk-Adjacentaccuknox.comin𝕏✓ verified

AccuKnox provides automated adversarial testing for large language models, machine learning models, and cloud AI infrastructure to detect security vulnerabilities including prompt injection, jailbreaks, hallucinations, and misconfigurations.

AI & Machine LearningCloud ComputingCybersecurityEnterprise Software

Rahul Jadhav(Founder)in

Co-investorsAvanta VenturesDreamit VenturesNational Grid PartnersMDSV CAPITALOutliers VCZ5 Capital

cloudclouddefense.ai𝕏✓ verified

AccuKnox provides an Application Security Posture Management (ASPM) platform that integrates vulnerability management, static and dynamic application security testing, software composition analysis, and infrastructure-as-code scanning to identify and prioritize security risks across the software development lifecycle for development and security teams.

AI & Machine LearningCloud ComputingCybersecurityDeveloper ToolsEnterprise Software

Co-investorsAvanta VenturesDreamit VenturesNational Grid PartnersSparq Capital (SFO)

Kuprion Inckuprioninc.comin✓ verifiedAcquired

Kuprion develops ActiveCopper materials and printable conductive inks used to manage heat in high-power, high-temperature electronic systems, serving electronics engineers and manufacturers across industries including semiconductor packaging, electric vehicles, and 5G communications.

HardwareNew MaterialsSemiconductorsSan Jose, US

Dr. Alfred Zinn(Founder)in

Co-investorsAlsop Louie PartnersStartup Capital Ventures

Neurotherapianeurotherapia.comin✓ verified

NeuroTherapia is a clinical-stage biotech company developing novel treatments for neuroinflammatory disorders, including Alzheimer's disease, neuropathic pain, multiple sclerosis, and ALS.

AI & Machine LearningBiotechDigital HealthHealthtechMedical DevicesCleveland, US

Co-investorsBrain Trust Accelerator Fund

Twelvetwelve.coin𝕏Apr 2015✓ verified

Twelve transforms CO2 into chemicals, fuels, and materials through carbon transformation technology.

Advanced ManufacturingCleantechClimate TechHealthtechNew MaterialsMoses Lake, US

Nicholas Flanders(Founder)inEtosha Cave(Founder)inKendra Kuhl(Founder)inAndrew Cleeland(Executive Officer, Director)in

BoardMarc-Henri Galletti(Director)Nimesh Shah(Director)

Co-investorsBreakout VenturesDCVC (Data Collective)Fifth WallAdvantage Partners Inc.Aera VCBreakout Labs+37 more

Vandriavandria.comin✓ verified

Vandria is a pharmaceutical development company focused on translating scientific innovation into first-in-class therapeutics.

BiotechHealthtechLongevityMedical DevicesLausanne, CH

Patrick Aebischer(Co-founder)Pénélope Andreux(Head of Research (mitochondrial research and development))inKlaus Dugi(Chief Medical Officer / Medical Leadership)inPeter(Business Development & Entrepreneurship Leadership)Leila(Operations Leadership)Anke Post(Chief Medical Officer / Neuroscience Leadership)

Co-investors+ND CapitalLevensohn Venture PartnersApollo Health Ventures

▶︎ CYTOVALEcytovale.comin𝕏

Cytovale develops microfluidic deformability cytometry technology for immune response diagnostics, with a focus on early detection and diagnosis in hospital settings.

BiotechDigital HealthHealthtechMedical DevicesSan Francisco, US

Ajay Shah(Founder)inHenry Tse(Co-founder & Chief Technology Officer)inDino DiCarlo(Director, Promoter)

BoardLindy Fishburne(Director)inJack Fuchs(Director, Promoter)in

Co-investorsAlumni VenturesBasecamp FundBlackhorn VenturesBreakout LabsBreakout VenturesEMV Capital+6 more

3Scan3scan.comNov 2014

San Francisco, US

Todd Huffman(Founder)Megan Klimen(Founder)

BoardJoshua Wolfe(Director)Matt Ocko(Director)inAdam Goulburn(Director)inAdam Goulborn(Director)

Co-investorsComet LabsRecode VenturesDCVC (Data Collective)Dimension CapitalLux CapitalOS Fund

8i8i.comin𝕏Nov 2016

8i develops virtual and augmented reality technologies for human connection and immersive experiences, serving audiences across entertainment, education, training, and professional settings.

AI & Machine LearningDeep TechMedia & EntertainmentLos Angeles, US

Lincoln Gasking(Executive Officer, Director)Hayes Mackaman(CEO)

BoardJames D Robinson(Director)inScott Levine(Director)Scott Nolan(Director)in

Co-investorsAdvancit CapitalRight Click CapitalRRE VenturesSamsung NextWestern Technology InvestmentFounders Fund

Acrigen Biosciencesacrigen.cominJun 2019

Acrigen develops precision gene editing systems based on CRISPR, using novel αCas and μCas nuclease libraries paired with engineered anti-CRISPR (ErAcr) proteins to reduce off-target edits.

BiotechDeep TechHealthtechKensington, US

Joseph Bondy-Denomy(Director)David Rabuka(Executive Officer, Director, Promoter)Karen Boezi(Director)

Co-investorsBerkeley Catalyst

Aether Bioaetherbio.comin𝕏

Aether develops additives that blend into engineering-grade nylons to enable faster, high-throughput fused filament (FFF/FDM) 3D printing while maintaining mechanical strength and dimensional accuracy.

Advanced ManufacturingAI & Machine LearningBiotechDeep TechHardwareNew Materials

Pavle Jeremic(Founder & CEO)inJay Zaveri(Co-Founder & President)

Co-investors4DX VenturesAbstract VenturesArtis VenturesBlue Bear VenturesBoxGroupCalm Ventures+13 more

All.Healthall.health

all.health offers an Integrated Continuous Management (ICM) platform combining a clinical-grade wearable with an FDA-recognized system that collects 24/7 vitals and biometrics, screens for disease risk, and links patients to their care teams.

AI & Machine LearningDigital HealthHealthtech

Co-investorsMindset VentureMorpheus VenturesSignalFireReinvent Capital

Alzeca Biosciencesalzeca.com

Develops targeted MR imaging agents for early detection of Alzheimer's and other neurodegenerative diseases.

Co-investorsCentral Texas Angel Network

Anthology Biotechnologiesanthology.bioin

Anthology develops designer and hybrid genomes by decoding genomic "language" to engineer microbes that convert feedstocks such as sugars, plastics, and agricultural waste into products like chemicals, materials, and food ingredients.

BiotechFoodTechNew Materials

Dr. Tzu-Chieh 'Zijay' Tang(CTO & Co-Founder)

Co-investorsAlumni VenturesCollaborative FundJuniperTaihill VentureThe E14 FundThe Engine Ventures

Astro Mechanicaastromecha.coin𝕏Seed

Astromecha designs engines, airframes, and flight systems for next-generation aerospace applications, including supersonic aircraft.

Advanced ManufacturingDeep TechHardwareSpace TechSan Francisco, US

Ian Brooke(CEO)in

Co-investorsAlumni VenturesAndreessen HorowitzBasecamp FundBlue Ivy VenturesEarthrise VenturesIndustrious Ventures+15 more

Athira Pharmaathira.com

A biotechnology company developing new therapies for patients with high unmet medical needs.

Biotech

Co-investorsLifeSci Venture PartnersSofinnova VenturesThe W FundViking GlobalCommodore CapitalFranklin Templeton+6 more

Atmosicatmosic.comin𝕏Dec 2019 · $28.5M

Atmosic designs ultra-low-power wireless connectivity and compute chips for connected devices, aiming to extend battery life or enable battery-free operation.

HardwareIoTSemiconductorsCampbell, US

David Su(Founder)inMasoud Zargari(Founder)in

Co-investorsClear VenturesSutter Hill VenturesWalden International

Atomwiseatomwise.comin

Atomwise uses artificial intelligence and machine learning to discover novel small-molecule drugs, with a current focus on developing treatments for immune and inflammatory diseases.

AI & Machine LearningBiotechDeep TechSan Francisco, US

Izhar Wallach(Founder)inAbraham Heifets(Founder)inYan Zhao(Executive Officer)inStephen Worland(Executive Officer, Director)

BoardRobert Mittendorff(Director)inAdam Seabrook(Director)in

Co-investorsAimTop VenturesAurum Venture PartnersB Capital GroupCerity Partners VenturesCreative Destruction Lab (CDL)Draper Associates+8 more

August Home Inc.august.comin𝕏acquired by Assa Abloy

August manufactures Wi-Fi-enabled smart locks and keypads that allow homeowners to remotely control door access and integrate with voice assistants like Alexa, Siri, and Google Assistant.

ConsumerHardwareIoTPropTechSan Francisco, US

Jason Johnson(Executive Officer, Director)in

BoardDavid Wu(Director)Michael Levit(Director)

Co-investorsBessemer Venture PartnersComcast VenturesCowboy VenturesGlobal BrainKDDI Open Innovation FundMaveron+8 more

Authentic Visionauthenticvision.cominFeb 2023 · $5M

Authentic Vision provides secure product digitalization solutions using holographic fingerprint technology and smartphone-based authentication to create copy-resistant product identities.

Advanced ManufacturingAI & Machine LearningCircular EconomyCybersecurityDeep TechEnterprise SoftwareFintechHardwareSaaSSalzburg, AT

Co-investorsJoint EffectsSmart Family Office

Bionautbionautlabs.comNov 2022 · $43M

Developing microscale robots to deliver therapies locally to targeted brain disease areas.

Co-investorsAlumni VenturesBlue Ivy VenturesBold Capital PartnersCompoundDeep InsightFlucas Ventures+9 more

Cajal Neurosciencecajal-tx.comin

Cajal Therapeutics develops novel therapies through translating scientific advances into treatments for patients.

AI & Machine LearningBiotechDeep TechDigital HealthMedical DevicesSeattle, US

Andrew Dervan(Co-Founder and Co-Chief Executive Officer)inIan Peikon(Co-Founder and Co-Chief Executive Officer)inRob Hershberg(Co-Founder and Executive Chairman)in

Co-investorsLux CapitalThe Column Group

Calacalahealth.comin𝕏

Cala Health develops non-invasive prescription therapies for movement disorders, starting with a treatment for hand tremor and essential tremor.

Deep TechDigital HealthHealthtechMedical DevicesSilicon Valley, US

Kate Rosenbluth, PhD(President & Chief Innovation Officer)Kate Rosenbluth(Founder)inDeanna Harshbarger(Founder)in

Co-investorsAlumni VenturesAscension VenturesGlobal BrainGV (Google Ventures)LifeSci Venture PartnersLightstone Ventures+5 more

Calicatcalicat.comOct 2024 · $3M

California Catalysts develops advanced materials and catalysts for hydrogen electrolysis using AI-driven discovery methods.

AI & Machine LearningCleantechEnergyNew MaterialsLos Angeles, US

Jim DiSanto(Co-founder, Board Director, Executive Consultant)inJourdan Urbach(CEO)

BoardNathan Lewis(Founder; Chief Scientific Advisor)

Co-investorsAcario InnovationMOL SwitchTSVCVoLo Earth VenturesMotus Ventures, Llc

Canaerycanaery.comin

Canaery develops a nose-computer interface that combines animal olfaction with neurotechnology and AI to detect substances and diagnose diseases.

AI & Machine LearningBiotechDeep TechHardwareMedical Devices

Gabriel(Chief Executive Officer)Peter(Chief Technology Officer)

BoardDmitry(Chief Science Advisor)

Co-investors15th RockFlorida Opportunity FundGood News VenturesNYU Innovation Venture FundBreakout VenturesKdT Ventures

Cato Digitalcato.digitalin𝕏

Cato Digital builds a bare metal cloud platform focused on maximizing data center capacity utilization through low-cost, low-carbon computing solutions.

AI & Machine LearningCleantechCloud ComputingData & InfrastructureDeep Tech

Co-investorsCowles Ventures

Cerevancecerevance.comin𝕏

Cerevance develops precision novel therapeutics for central nervous system disorders, particularly neurodegenerative diseases, using its proprietary NETSseq platform and machine learning to identify targets from an extensive collection of human brain tissue samples.

AI & Machine LearningBiotechDeep TechHealthtechMedical DevicesBoston, US

Craig Thompson(Chief Executive Officer)inSagar Vaidya(Chief Medical Officer)inCarrie Ann Cook(Chief Business Officer)Mark Carlton(Chief Scientific Officer)inOttavio V. Vitolo(Chief Medical Officer)in

Co-investorsDementia Discovery FundForesite CapitalGV (Google Ventures)SV Life SciencesDementia DiscoveryLightstone Ventures+4 more

CoformerAIcoformer.ai

Accelerates coformer discovery using molecular mechanism models to overcome solubility and bioavailability barriers.

Cognition Therapeuticscogrx.comin𝕏

Cognition Therapeutics is a clinical-stage biotechnology company developing zervimesine (CT1812), an investigational once-daily oral small-molecule therapy designed to protect brain synapses by blocking toxic protein oligomers.

BiotechHealthtechPittsburgh, US

Susan Catalano(Executive Officer, Director)inSusan Catalano, Ph.D.(Co-founder)Lisa Ricciardi(Chief Executive Officer)inHarold Safferstein(Executive Officer, Director)

BoardNada Jain(Director)Franz Hefti(Director)

Co-investors3E Bioventures CapitalArieal Southeast Angel PartnersAtlanta Technology AngelsBios PartnersCowtown AngelsGolden Seeds+2 more

Cognitive Spacecognitivespace.comin𝕏Seed · Oct 2023 · $4M

Cognitive Space develops AI-driven automation software for satellite operations, enabling constellation operators to scale while meeting operational requirements.

AI & Machine LearningDefense TechSaaSSpace TechHouston, US

Marc Bell(Co-Founder and CEO)Guy de Carufel(Founder)inDax Garner(CTO)inJeff Edwards(VP of Engineering)inHanna Steplewska(Executive Officer, Director)Jennifer Roberts(Director)in

Co-investorsArgon VenturesCapital InnovatorsCreative Destruction Lab (CDL)Draper AssociatesGlasswing VenturesGrit Ventures+10 more

Cogstatecogstate.comin𝕏

Cogstate provides digital cognitive assessments, electronic clinical outcome assessment (eCOA) support, and endpoint data quality services for biopharmaceutical companies, academic institutions, and clinicians.

BiotechDigital HealthHealthtechMedical DevicesMelbourne, AU

Brad O'Connor(Chief Executive Officer)inDr. Ventola(Chief Science Officer)

Co-investorsEisai Innovation, Inc.

Cortexymecortexyme.com

Casey Lynch(Founder)Kristen Gafric(Founder)Stephen Dominy(Founder)

Co-investorsPfizer Venture InvestmentsSofinnova Partners

Cquestacquesta.comin

Cquesta develops crop varieties with enhanced root systems to increase agricultural productivity and sequester carbon in soil.

AgTechBiotechCleantechClimate Tech

Andrew Baum(CEO)Tim Ulmasov(President and CSO)in

Co-investorsBezos Earth Fund

Delixdelixtherapeutics.cominSep 2021 · $70M

Delix Therapeutics develops third-generation, non-hallucinogenic neuroplastogens for people with neurological conditions, using a discovery platform to identify novel compounds.

BiotechDigital HealthMedical Devices

David Olson(Founder)David Olson Nick Haft(Founder)Nick Haft(Founder)

Co-investorsArtis VenturesBailey Venture PartnersCasa Verde CapitalGaingelsIaso VenturesNoetic+9 more

Densitydensityai.com

Density AI designs custom AI accelerators optimized for frontier-scale large language model inference, combining near-memory compute architecture with high-bandwidth memory density.

AI & Machine LearningDeep TechMountain View, US

Ben Floering(Founder)Bill Chang(Founder)Ganesh Venkat(Founder)

Co-investorsFirestreak VenturesHyphen Capitalimec.xpandNextGen Venture PartnersSouth Park CommonsStartX+5 more

Diamond Agediamondage3d.comin

Robotic systems and 3D printing company innovating at industrial scale to transform homebuilding.

Jack Oslan(Founder)Russel Varone(Founder)

Co-investorsAlumni VenturesGaingelsPerot JainSuffolk TechnologiesAlpaca VCCalm Ventures+2 more

DigiLendsdigilens.comin𝕏Apr 2018

DigiLens develops waveguide optics and holographic display technology using a proprietary material set combined with inkjet printing and a holographic contact copy process.

Deep TechHardwareNew MaterialsSunnyvale, US

Jonathan Waldern(Director)inChristopher Pickett(Executive Officer, Director)Patrick Suel(Director)Robert Young(Director)Thorsten Alexander Kern(Director)

BoardJim Whims(Director)

Co-investorsAlsop Louie PartnersBold Capital PartnersDiamond Edge VenturesIn-Q-TelNautilus Ventures Management Company (Us), LlcSony Ventures Corporation+2 more

Discover Echodiscover-echo.com

Developed table-driven bright field and fluorescent hybrid microscopes.

HealthtechSan Diego, US

Eugene Cho(Executive Officer, Director)

Co-investorsGreen Park & Golf VenturesThe Perkins FundWestern Technology InvestmentTech Coast Angels

Eargoeargo.comDec 2018Defunct

Eargo was a hearing aid company that provided high-quality hearing aids and related care services.

HealthtechMedical DevicesMountain View, US

Raphael Michel(Founder)Christian Gormsen(Executive Officer, Director)William Brownie(Executive Officer)Peter Tuxen Bisgaard(Director)Daniel Shen(Founder)Florent Michel(Founder)

Co-investorsBirchmere VenturesLongitude CapitalMaveronNew Enterprise Associates (NEA)Peterson VenturesCrosslink Capital+4 more

EnClear Therapiesencleartherapies.cominFeb 2024

EnClear Therapies is a bio/med-tech company developing the EnTrega CSF platform, focused on cerebrospinal fluid-related therapies.

BiotechDigital HealthHealthtechMedical DevicesCambridge, US

Anthony DePasqua(Executive Officer, Director)inKevin Kalish(COO)inMarcie Glicksman(VP Biology)inWilliam Gormley(CMO)Jason Camm(Director)Kasper Roet(Director)in

Co-investors20/20 HealthCare Partners LLCFlucas VenturesTachyon VenturesVU Venture PartnersAmgen VenturesBioverge+1 more

Envisagenicsenvisagenics.cominSep 2021

Envisagenics uses AI-driven analysis of RNA splicing to discover novel drug targets for immuno-oncology and neurodegenerative diseases.

AI & Machine LearningBiotechMedical DevicesNew York, US

Martin Akerman, PhD(CEO & Co-founder)Martin Akerman(Founder)inMaria Luisa Pineda(Founder)in

Co-investorsDynamk CapitalHAWKTAILM12 (Microsoft's Venture Fund)Madrona Venture GroupRed Cell IncubationThird Kind Venture Capital

Esperesper.ioin𝕏

Esper provides device management software using DevOps principles for company-managed devices, automating provisioning and exception-based management across Android and other platforms.

Developer ToolsEnterprise SoftwareIoTBellevue, US

Shiv Sundar(Founder)inYadhu Gopalan(Founder)inJoe Lonsdale(Founder)Lilli Oetting(Founder)Maleka Momand(Founder)

Co-investorsGRIDS CapitalMadrona Venture GroupNimble PartnersPathbreaker VenturesRoot Ventures Manager, LlcUbiquity Ventures+5 more

Esper Satellite Imageryespersatellites.coin𝕏

Esper provides hyperspectral satellite imagery and geochemical analysis to identify critical minerals and alteration zones for mining exploration and environmental monitoring.

AgTechDeep TechSpace TechPatterson Lakes, AU

JoeyShoaib Iqbal(Founder)inPrzemyslaw Lorenczak(Founder)

Co-investorsCroc PitchInvestible Climate Tech FundNZVCScale Venture PartnersStellarTechstars

Exciva Gmbhexciva.com

Exciva is a company focused on neurological and neurodegenerative conditions, led by a team with expertise in chemistry, clinical operations, and regulatory affairs.

BiotechDigital HealthLongevityMedical DevicesHeidelberg, DE

Hans Moebius(Co-founder and CMO, Head of Clinical Operations)inAnton Bespalov(Co-founder and CSO, Head of Regulatory Affairs)in

Co-investorsAndera PartnersCARMA FUNDFountain Healthcare PartnersGimvLBBW Venture Capital GmbHLifeArc Ventures+1 more

Genemodgenemod.netin𝕏Aug 2020 · $4.5M

Genemod offers a lab management platform that combines electronic lab notebook (ELN), LIMS, inventory, and equipment tracking in one data model, with AI agents that plan experiments, execute protocols across connected systems, and generate audit-ready records.

AI & Machine LearningBiotechHealthtechSaaSEdmonds, US

Jacob Lee(Executive Officer, Director, Promoter)inZachary Gut(Director)Michael Gregoire(Director)Jin Choe(Director, Promoter)Anil Arora(Executive Officer)

BoardNeil Sequeira(Director)in

Co-investorsAmino CapitalDefy Partnersfutureland venturesLDV Partners

General Sensegeneralsense.comin

General Sense develops detection technology that augments trained detection animals, aiming to identify molecular threats such as narcotics, crop diseases, human diseases, and bioweapons.

BiotechDeep TechDefense TechHardware

Peter Ledochowitsch(CTO & Co-Founder)inWestley Dang(CEO)in

Co-investors15th RockBreakout VenturesDraper AssociatesJuniperKdT VenturesSOSV

Herophilusherophilus.comin𝕏

Herophilus develops neurological drug discovery by combining human brain models, scaled biology, and machine learning to identify and develop novel drugs for complex brain diseases.

AI & Machine LearningBiotechHealthtech

Co-investors515 VenturesBoom Capital VenturesKinled HoldingBoom Capital

Hyperfine Researchhyperfinemri.comin𝕏

Hyperfine develops the Swoop portable, point-of-care MRI system for brain imaging without ionizing radiation, used in clinical and research settings for infants, children, and adults.

AI & Machine LearningDigital HealthHealthtechMedical Devices

Jonathan Rothberg(Founder)in

Co-investorsDAYLI PartnersGV (Google Ventures)

ICON Aircrafticonaircraft.com𝕏Mar 2019

ICON Aircraft designs, builds, and certifies Light-Sport Aircraft, notably the ICON A5, and offers customer sales, service, and flight training.

Advanced ManufacturingHardwareMobility & TransportationVacaville, US

Kirk Hawkins(Executive Officer, Director)Rich Bridge(Executive Officer)Thomas Wieners(Executive Officer)Katherine DeHoff(Executive Officer)Rodolfo (Rudy) Correa(Vice President, Operations)Amy Xu(Interim CFO & Corporate Secretary)

Co-investorsSeraph GroupWestern Technology Investment

IRIS MEDICINEirismedicine.comin

Iris Medicine is an early-stage biotech developing RNA therapies based on its small binding RNA (sbRNA) platform, which uses cooperative RNAi binding to selectively silence mutant genes carrying expanded pathologic repeat sequences while preserving healthy alleles.

BiotechDeep TechHealthtech

Megan Matthews(Co-founder & President)Megan Blewett(Founder)

Co-investorsVenrockUCB VenturesPsyMed Ventures

Iterum Therapeuticsiterumtx.comSeries B · May 2017 · $65M

Iterum Therapeutics develops anti-infective compounds to treat infections caused by multi-drug resistant pathogens.

BiotechDigital HealthHealthtechMedical DevicesDublin, US

Michael W. Dunne(Executive Officer, Promoter)inCorey N. Fishman(Executive Officer, Director, Promoter)inJudith M. Matthews(Executive Officer, Promoter)Jeff Schaffnit(Executive Officer)

BoardBrenton K. Ahrens(Director)Ronald M. Hunt(Director)

Co-investorsBay City CapitalCanaan PartnersSofinnova VenturesAdvent Life SciencesFrazier Life SciencesSofinnova Venture Partners

Kebotixkebotix.comin𝕏

Kebotix uses artificial intelligence, machine learning, and laboratory automation to discover and develop new materials and molecules.

AI & Machine LearningDeep TechNew MaterialsCambridge, US

Dennis Sheberla(Executive Officer)inSemion Saykin(Executive Officer)Alan Aspuru-Guzik(Executive Officer)inAshish Kulkarni(Chairman and CEO)in

BoardTong Hui(Director)Andrew Krowne(Director)in

Co-investorsArcTern VenturesBantam GroupConstructor Capital USEmbark VenturesFlybridge Capital PartnersOne Way Ventures+6 more

Keyssakeyssa.comAug 2017

Next-generation wireless connector delivering 6 Gbps over secure EHF transmission.

Campbell, US

Eric Almgren(Executive Officer, Director)Gordon Almquist(Executive Officer)

BoardAnthony Fadell(Director)Rahul Chaturvedi(Director)Surendra Mandava(Director)Don McKinney(Director)

Co-investorsIn-Q-TelSamsung Catalyst FundAlsop Louie PartnersIntel CapitalNeuberger Berman

Leap Motionultraleap.com

Ultraleap develops hand-tracking and haptics technology for spatial interaction, with applications in music education and consumer products like the Airwave piano interface.

AI & Machine LearningConsumerHardwareBristol, GB

Michael Buckwald(Cofounder)David Holz(Cofounder)Tom Carter(Founder)inBenjamin Long(Founder)in

Co-investorsQBN CapitalAndreessen HorowitzFounders FundHighland Capital PartnersJ.P. Morgan Asset Management

Leo Labsleolabs.spacein𝕏

LeoLabs operates a network of ground-based radars and an AI-enabled cloud platform that tracks and maps objects and activity in low Earth orbit.

AI & Machine LearningDefense TechSpace TechMenlo Park, US

Daniel Ceperley(Founder & Chief Operating Officer)inEdward Lu(Founder & Chief Technology Officer)Michael Nicolls(Founder)Tony Frazier(Chief Executive Officer)John Buonocore(Founder & Chief Engineer)

Co-investorsAlumni VenturesDefence TrailblazerHemisphere Ventures LLCMDSV CAPITALNZ Growth Capital PartnersSeraphim Space+6 more

Libra Therapeuticslibratherapeutics.comin𝕏

Libra Therapeutics develops small molecule therapeutics targeting lysosomal function and autophagy to treat neurodegenerative diseases including ALS, Parkinson's, Alzheimer's, and Huntington's disease.

BiotechLongevityMedical Devices

Dr. Gill(Chief Scientific Officer)

Co-investorsEpidarex CapitalAMR Action FundBoehringer Ingelheim Venture Fund

Lightformlightform.comin𝕏Seed · Nov 2017 · $5M

Lightform develops design tools for projected augmented reality, combining computer vision and hardware to enable interactive visual experiences.

AI & Machine LearningDeep TechDeveloper ToolsHardware

Co-investorsComet LabsGen CapitalPresence CapitalTuesday CapitalAnorak VenturesLevensohn Venture Partners+2 more

M3m3db.ioNov 2017 · $15.2M

M3 is an open source metrics platform, originally developed by Uber's Observability team in 2014, built around a purpose-built time series database (M3DB), a query engine, and ingestion/aggregation components.

Cloud ComputingData & InfrastructureDeveloper Tools

Co-investorsCardinia Ventures

Magnefymagnefy.comin

Magnefy develops hybrid magnetic sensing and signal-processing hardware combined with AI/ML for monitoring critical infrastructure in harsh, real-world environments.

Deep TechHardwareIoTPalo Alto, US

Joseph Kao(CEO & Co-Founder)inDerrick Du(Founding Product Manager)inAsma Mahar(Head of Hardware - Sensors & Signal Processing)in

Co-investorsDangerous VenturesImpact Ventures Management Pty LtdStartXSunna Ventures

magnusmagnusmed.comin𝕏Feb 2025

Magnus Medical develops SAINT, an FDA-cleared, accelerated form of TMS (transcranial magnetic stimulation) therapy that uses precision neuromodulation to treat Major Depressive Disorder, including treatment-resistant depression, over a 5-day course.

BiotechDigital HealthMedical DevicesMental HealthBurlingame, US

Nolan Williams(Director)Christian Gormsen(Executive Officer, Director)inVikram Lamba(Executive Officer)in

BoardXingjuan Chao(Director)inAndrew Firlik(Director)inHeath Lukatch(Director)

Co-investorsJAZZ Venture PartnersRed Tree Venture

MedCryptmedcrypt.comin𝕏Series B · Nov 2022

MedCrypt provides a cybersecurity toolkit for medical device manufacturers, helping their devices meet security regulations and detect malicious attacks.

CybersecurityDigital HealthHealthtechMedical DevicesSaaSSan Diego, US

Eric Pancoast(CTO)inMike Kijewski(CEO)inVidya Murthy(VP of Operations)inWilliam Fenstermaker(Founder)Om Mahida(Engineer)Erin Murphree(talent acquisition)

Co-investorsEniac VenturesIntuitive VenturesY CombinatorSection 32Alumni VenturesAnzu Partners+10 more

MindImmune Therapeuticsmindimmune.comSeries A · Nov 2025 · $12M

MindImmune develops therapeutics targeting the immune drivers of neurodegenerative diseases such as Alzheimer's, focusing on immune cells that respond to amyloid plaques before they enter the brain.

BiotechHealthtechKingston, US

Robert B. Nelson(Executive Officer, Director)Frank S. Menniti(Executive Officer, Director)inStevin Zorn(Executive Officer, Director)inIsaac Stoner(CEO)in

BoardRichard G. Horan(Director)Reetika Bhardwaj(Director)in

Co-investorsPfizer Venture InvestmentsSlater Technology FundARCH Venture PartnersPfizer Ventures

Mojo Visionmojo.visionin𝕏

Mojo Vision develops micro-LED technology, positioning it as a platform for AI infrastructure and next-generation displays.

Deep TechHardwareSemiconductors

Drew Perkins(Founder)inNikhil Balram(Chief Executive Officer)inMike Wiemer(Chief Technology Officer)inG. Aaron James(General Counsel)inMichael Deering(Founder)Michael Wiemer(Founder)

Co-investorsARC Angel FundArgonautic VenturesBold Capital PartnersDisney AcceleratorFlucas VenturesFusion+20 more

Molten Salt Solutionsmoltensaltsolutions.cominOct 2024

Molten Salt Solutions develops advanced materials for next-generation nuclear power, including lithium isotope enrichment enabled by proprietary chromatography separation and mass spectrometry technologies.

Deep TechEnergyNew MaterialsSanta Fe, US

John Elling(Executive Officer)in

Co-investorsFuture VenturesTrue VenturesBaruch Future Ventures

Montara Therapeuticsmontaratx.comin

Montara is a biotech company developing small-molecule therapeutics focused on neurodegeneration and diseases such as Alzheimer's.

AI & Machine LearningBiotechDeep TechSan Francisco, US

Kevan Shokat(Co-Scientific Founder & Chairman of the SAB)Thomas Südhof(Co-Scientific Founder & SAB Member)Seth Stratton(Director)Dirk Langdorf(Director)Nicholas Hertz(Executive Officer, Director)

Co-investorsBEVCKdT VenturesSV Health InvestorsTwo Bear CapitalDementia Discovery Fund

Monument Biosciencesmonument.bioin

Monument Biosciences is a biotechnology company developing disease-modifying drugs for Alzheimer's Disease and Related Dementias (ADRD).

BiotechDigital Health

Co-investorsElevate VenturesIU Ventures

Moovemoove.aiinMar 2023

Moove.ai applies machine learning to real-time connected vehicle data to assess transportation risk and build mitigation tools focused on road safety and efficiency.

AI & Machine LearningData & InfrastructureMobility & TransportationLafayette, US

Rafay KhaninJack Greco(Director)inSalman Dhanani(Director)Abdur Rafay Khan(Executive Officer, Director)

BoardLauren Deluca(Director)in

Co-investorsCortado VenturesMotivate Venture CapitalService Provider CapitalUber

Motif Neurotechmotifneuro.techin𝕏Jan 2024 · $19M

Motif Neurotech develops a therapeutic brain-computer interface using minimally invasive neuromodulation to treat difficult-to-treat mental health conditions such as depression.

BiotechDeep TechDigital HealthHealthtechMedical DevicesHouston, US

Sameer Sheth(Founder)inSunil Sheth(Founder)Nick Halper(Chief Operating Officer)inSteve Goetz(Chief Technology Officer)inAnthony Arnold(Director)inKaiyuan Yang(Founder)

Co-investorsArboretum VenturesDivergent CapitalFeatures Capital HoldingsKdT VenturesPsyMed VenturesTMC Venture Fund+6 more

Motiv Ringmymotiv.com

Motiv makes a lightweight titanium smart ring that tracks fitness, sleep, and heart rate for everyday consumers.

ConsumerHardwareWellness & Fitness

NeuroBionicsneurobionics.ioinNov 2025

NeuroBionics develops soft, flexible neural interface technologies for neuromodulation applications.

BiotechDeep TechHealthtechMedical DevicesSomerville, US

MJ Antonini(Founder, CEO)inNicki Driscoll(Founder, CTO)Polina Anikeeva(Founder)inNicolette Driscoll(Founder)in

Co-investorsDevice of Tomorrow CapitalEmpath VenturesFuture VenturesGreyMatterMana VenturesPioneer+4 more

New Matternewmatter.comNov 2014

Founded 2014 to bring 3D printing to homes, schools and offices via the MOD-t.

Pasadena, US

Steve Schell(Executive Officer, Director)inDeborah Chen(Executive Officer)Christopher Stone(Executive Officer)Craig Chrisney(Executive Officer)

BoardGilman Louie(Director)Marcia Goodstein(Executive Officer)

Co-investorsIdealab

NextSensenextsense.ioinJun 2022

NextSense makes Smartbuds, EEG earbuds with dry-contact sensors that measure brain activity and adapt audio in real time to increase deep sleep, meditation, and focus.

Digital HealthHardwareWellness & FitnessMountain View, US

Jonathan Berent(Founder & CEO | Board Director)inBradley Horowitz(Director)

BoardJohn Kuelper(Director)QuHarrison Terry(Director)

Co-investorsAscension VenturesGV (Google Ventures)Joy VenturesPrime Movers Lab

Nianticnianticlabs.comacquired by Scopely, Inc.

Niantic Labs develops mobile games and apps that encourage outdoor exploration and real-world community engagement through location-based gaming experiences.

ConsumerGamingSan Francisco, US

John Hanke(Founder)Phil Keslin(Founder)

BoardKenji Okubo(Director)

Co-investorsAloft VCBattery VenturesBonfire VenturesBreyer CapitalCapitalGCauseway Partners+14 more

Niantic Spatialnianticspatial.comin𝕏May 2025

Niantic Spatial builds real-world foundation models for physical AI, offering capabilities to reconstruct geometrically accurate 3D digital twins, localize devices without relying on GPS via a Visual Positioning System, and interpret 3D environments.

AI & Machine LearningDeep TechRoboticsSan Francisco, US

John Hanke(Founder & Executive Chairman)inKatherine Richard-Dodson(Executive Officer)Christopher Chow(Executive Officer)Thomas Gewecke(Executive Officer)inInhi Cho Suh(Chief Executive Officer)in

BoardGilman Louie(Director)in

Co-investorsAlsop Louie PartnersJavelin Venture PartnersScopely

Noon Homenoonhome.com

Intelligent lighting controls for residential and commercial lighting.

Annie Cheung(Cofounder)

Numerion Labsnumerionlabs.aiin𝕏Series B

Numerion Labs develops machine learning algorithms for drug discovery, combining computational chemistry, structural biology, and medicinal chemistry.

AI & Machine LearningBiotechDeep TechHealthtechMedical DevicesSan Francisco, US

Alex Levy(Founder)inIzhar Wallach(Founder)inSteve Worland(CEO)inPamela Tsuruda(VP, Biology)Mark Sabat(VP, Medicinal Chemistry)inKate Stafford(VP, Machine Learning)in

Co-investorsB Capital GroupB4 CapitalColorcon VenturesDCVC (Data Collective)NEXT CanadaY Combinator+12 more

OKAPI:Orbitsokapiorbits.spacein

OKAPI:Orbits provides AI-based Space Traffic Management (STM) and Space Situational Awareness (SSA) software platforms along with consulting services for satellite operators.

AI & Machine LearningSaaSSpace TechBraunschweig, DE

Kristina Nikolaus(Founder)in

Co-investorsAmadeus Capital PartnersAPEX VenturesMatterwave VenturesVentechHeadlineMunich Re Ventures

Paradromicsparadromics.comin𝕏Jul 2021

Paradromics develops a brain-computer interface (BCI) system, with FDA Breakthrough Device Designations for speech decoding and digital device control, and works with academic medical institutions on translational BCI research.

BiotechDeep TechHealthtechMedical DevicesAustin, US

Matt Angle(Founder and CEO)inRon Kelly(Director)Thomas Krummel(Director)Adam Kablanian(Director)

Co-investors15th RockAlpha EdisonAnthropy PartnersATEL VenturesCapital FactoryCloudStone Capital+27 more

Pharmatrophixpharmatrophix.comin

Pharmatrophix is developing a small-molecule drug for Alzheimer's disease that acts upstream of amyloid, with Phase 2a trial imaging showing dose-dependent preservation of whole-brain connectivity.

BiotechHealthtechRaleigh, US

Frank M. Longo(Director)inAnne C. Longo(Executive Officer)in

BoardRobert Sims(Director)

Phase Fourphasefour.ioAcquired

Phase Four developed in-space electric and multi-mode satellite propulsion; its technology assets were sold in 2025.

Hawthorne, US

STEPHEN KISER(Executive Officer, Director)inSimon Halpern(Executive Officer, Director)

BoardStewart Alsop(Director)inTHOMAS J.A. LAVIN(Director)JAMES BRIDENSTINE(Director)

Co-investorsAlsop Louie PartnersAlumni VenturesAutochrome VenturesIndustrious VenturesNew Science VenturesWestern Technology Investment+1 more

Phylagenphylagen.comFeb 2019

Technology identifying supply chain sources using the environmental microbiome.

Jessica Green(Founder)inHarrison Dillon(Founder)in

Co-investorsGolden SeedsJ-VenturesWestern Technology InvestmentWorking Capital FundAgFunderBlackhorn Ventures+4 more

Podium Datapodiumdata.comin𝕏

Enables businesses to consolidate data into Hadoop-based data lakes for analytics.

AI & Machine LearningCloud ComputingData & InfrastructureEnterprise Software

Co-investorsConverge

Potatopotato.aiinApr 2025 · $4.5M

Potato builds software that connects scientific research intent to laboratory execution, enabling research teams to accelerate the translation from experimental design to hands-on lab work.

AI & Machine LearningBiotechDeep TechSaaS

Merrit Savener(VP of Commercial)

Co-investorsAllen Institute for AI (AI2) IncubatorDraper AssociatesEnsemble VCGaingelsAlumni VenturesBoost VC+7 more

Precision Neuroscienceprecisionneuro.ioin𝕏

Precision Neuroscience develops a minimally invasive, high-bandwidth brain-computer interface, including its Layer 7 cortical interface, initially aimed at helping people with paralysis control digital devices and robotics using their thoughts.

Deep TechDigital HealthHealthtechMedical DevicesNew York, US

Benjamin Rapoport(President, Chief Science Officer)inMichael Mager(Chief Executive Officer)inCraig Mermel(President and Chief Product Officer)inMIchael Kaswan(Chief Financial Officer)Konstantinos Alataris(President)inBenjamin Rapoport Michael Mager(Founder)

Co-investorsAlumni VenturesB Capital GroupB4 CapitalBasecamp FundDraper AssociatesForepont Capital Partners+5 more

Progentos Therapeuticsprogentos.comMay 2024 · $65M

Progentos develops small-molecule therapeutics to stimulate myelin regeneration in multiple sclerosis patients by activating oligodendrocyte progenitor cells.

BiotechDeep TechMedical DevicesWatertown, US

Dmitrij Hristodorov(Director)inChristopher Loose(Executive Officer, Director)Sanjay Magavi(Executive Officer)Marc-Olivier Turgeon(Director)in

BoardAleks Radovic-Moreno(Director)inDan Janney(Director)

Co-investorsAlta PartnersLongwood FundMission BiocapitalService Provider CapitalForbion

Qlikqlik.comin𝕏

Qlik provides a data integration and analytics platform, including an agentic AI framework, that helps enterprises turn their data into insights and actions for business decisions.

AI & Machine LearningData & InfrastructureEnterprise SoftwareSaaS

Co-investorsAccelIndustrifondenJerusalem Venture Partners (JVP)Lighthouse Network Ventures LlcThoma Bravo

Quralisquralis.comin𝕏Mar 2023

QurAlis develops precision therapies for amyotrophic lateral sclerosis (ALS) and related neurodegenerative diseases by targeting specific disease-causing genetic drivers and molecular mechanisms.

BiotechDeep TechMedical DevicesCambridge, US

Kevin Eggan(Founder, QurAlis; Group Vice President, Head of Research and Early Development, BioMarin Pharmaceutical)inRoet(Co-founder)Woolf(Co-founder)Kasper Roet(Founder, Chief Executive Officer)inShafique Virani(Executive Officer)inJason Brown(Mr. Brown is the Chief Financial Officer of the Issuer.)in

Co-investorsALS Investment FundDroia VenturesInkefMC Healthcare VenturesMission BiocapitalMitsui Global Investment+8 more

Readysetpotatoreadysetpotato.comin

Potato builds software that bridges scientific research and laboratory execution, enabling research teams to move from hypothesis to experiment to learning faster by automating the manual processes between scientific intent and real-world lab work.

AI & Machine LearningBiotechDeep TechSaaS

Merrit Savener(VP of Commercial)

Co-investorsAlumni VenturesDraper AssociatesPhase Two VenturesRoble VenturesEnsemble VC

REGENTregentcraft.comin𝕏

REGENT designs and manufactures Seaglider wing-in-ground-effect aircraft for regional coastal transportation and defense logistics, offering high-speed zero-emission travel between coastal cities and military applications.

Advanced ManufacturingCleantechClimate TechDefense TechHardwareMobility & TransportationSpace TechNorth Kingstown, US

Billy Thalheimer(Founder)inMichael Klinker(Founder)inMike Klinker(Founder)Tom Harari(Vice President Strategy \u0026 Corporate Development)inSusan Hendrix(Lead Technical Recruiter)Jody Simon(Sourcing Lead)

Co-investorsFounders FundAurum Venture PartnersDarco CapitalFuture Planet CapitalGlobal BrainGraph Ventures+31 more

Reservoir Neurosciencereservoirneuro.com

Reservoir Neuroscience is developing therapeutics aimed at repairing the blood-brain barrier.

BiotechHealthtechSan Francisco, US

Aaron Friedman(Executive Officer)Vladimir Senatorov(Director)

BoardTracy Saxton(Director)James Summers(Director)Brian Slingerland(Director)

Co-investorsage1

Rovieroroviero.com

Native graph processor architecture enabling a programmable neural network engine for edge AI.

Co-investorsMonta Vista Capital

Salvia Bioelectronicssalviabioelectronics.com

Neuromodulation therapy for migraine relief.

Eindhoven, NL

Hubert Martens(Co-founder; Chief Executive Officer)Daniel Schobben(Co-founder; Chief Innovation Officer)Dr. Wim Pollet(Co-founder; Chief Medical Officer)

Co-investorsInkefInnovation IndustriesLevensohn Venture PartnersPanakes PartnersSHS CapitalThuja Capital

Sea Machines Roboticssea-machines.comin𝕏Oct 2020 · $20M

Sea Machines develops autonomous command and control technology and computer vision systems for maritime vessels.

Advanced ManufacturingAI & Machine LearningDefense TechHardwareIoTRoboticsBoston, US

Michael G. Johnson(Founder and CEO)in

Co-investorsAccompliceToyota VenturesEmerald Technology Ventures AgGeekdomLaunchCapitalLDV Capital+8 more

Sensorium Therapeuticssensorium.bioinJul 2021

Sensorium Therapeutics is a clinical-stage biotech company developing novel CNS therapies for anxiety, epilepsy, and cognitive dysfunction using its SensAI platform, which integrates AI, chemistry, and curated natural product data to identify therapeutic patterns from over 50 million biological relationships.

AI & Machine LearningBiotechDigital HealthMedford, US

Jerrold Rosenbaum(Co-Founder & Chair Emeritus, Massachusetts General Hospital (MGH) Department of Psychiatry)inJacob Hooker(Co-Founder & Chief Executive Officer)inPranav Tadi(Executive Officer)Stephen Haggarty, PhD(Co-Founder & Professor of Neurology, Harvard Medical School)Dick Simon, MBA(Co-Founder)

BoardRyan Katz(Director)in

Co-investorsBonaventure Equity, LLCHatteras Venture PartnersIter InvestmentsMission BiocapitalPalo Santo VCRoute 66 Ventures+4 more

Sepionsepiontechnologies.cominOct 2021

Sepion develops advanced polymer separator technology for batteries and other applications including water separation and materials recovery.

CleantechDeep TechEnergyNew MaterialsSilicon Valley, US

Peter Frischmann(CEO & Co-Founder)inBrett Helms(CSO & Co-Founder)in

BoardRandy Chan(Director)

Co-investorsACVC PartnersAlumni VenturesCreative VenturesFine Structures VenturesFoothill VenturesGaingels+4 more

Sharrow Marinesharrowmarine.comin𝕏Jun 2023 · $30M

Sharrow Marine designs and manufactures the patented SHARROW propeller, a bolt-on marine propulsion product that improves boat range, handling, vibration, and noise across a wide variety of boat and engine brands.

Advanced ManufacturingHardwareMobility & TransportationDetroit, US

Co-investorsWakestream Ventures

Soil Actionsoilaction.com

Sensor and AI platform delivering real-time on-tractor soil chemistry analysis for smart fertilizer application.

Co-investorsAg Ventures AllianceAgLaunch AcceleratorR7 Partners

Sourcesource.spacein𝕏

SOURCE develops space-grade solar panels and arrays for spacecraft applications including earth observation, space-object observation, positioning, and exploration missions.

EnergyHardwareSpace TechLongmont, US

Philip Keller(CEO and Co-Founder)inBryan Mazor(Co-Founder)in

Co-investorsAlpine Space Ventures

Stellarstellar.aeroin𝕏

Stellar builds an operations management platform for business aviation fleets, offering scheduling, quoting, trip management, and data analytics integrated into a single cloud solution.

B2B MarketplacesEnterprise SoftwareSaaS

Co-investorsWestern Technology Investment

Strateosstrateos.comin𝕏Apr 2019

Strateos develops remote access laboratory software and automation platforms that enable scientists to design, execute, and analyze experiments through cloud-based robotics and control systems.

AI & Machine LearningBiotechDeep TechRoboticsSaaSMenlo Park, US

Chris Krueger(Executive Officer)inMark Fischer-Colbrie(Executive Officer, Director)inDavid Lynch, PhD(Chief Executive Officer)Marc Siladi(Chief Operating Officer)in

BoardJoshua Wolfe(Director)Armen Vidian(Director)in

Co-investorsDCVC (Data Collective)Lux CapitalBlueStone Venture PartnersThird Rock VenturesAlumni VenturesHarmonix Fund+6 more

Switch Therapeuticsswitchthera.comin

Switch Therapeutics develops RNA interference (RNAi) therapeutic applications targeting central nervous system diseases, leveraging research from Caltech, Harvard Medical School, and City of Hope.

AI & Machine LearningBiotechDeep TechMedical DevicesSouth San Francisco, US

Si-Ping Han(Secretary)inDeepshikha Datta(Chief Executive Officer and President)

BoardKevin Zhang(Director)Alicia Irurzun-Lafitte(Director)inDylan Morris(Director)in

Co-investorsBold Capital PartnersCRV (Charles River Ventures)FREEFLOWGlobal BrainOno Venture Investment, Inc.Upfront Ventures+3 more

Tempo Automationtempoautomation.com

San Francisco, US

Shashank Samala(Founder)Jeffrey McAlvay(Executive Officer, Director)Jesse Koenig(Founder)Jeff McAlvay(Founder)

Co-investors1843 CapitalAlumni VenturesGrit VenturesKeiretsu ForumLux CapitalPoint72 Ventures+6 more

Tetra Therapeuticstetradiscovery.com

Tetra Discovery Partners (d/b/a Tetra Therapeutics) was a clinical-stage biopharmaceutical company whose clinical trials and research programs were acquired by Shionogi & Co., Ltd. in 2020 and are now managed by Shionogi's U.S. subsidiary.

Biotech

Co-investorsMichigan Capital Network

Tetra Therapeuticstetratherapeutics.comSeries A · Nov 2016 · $5M

Tetra Therapeutics (Tetra Discovery Partners) was a discovery-based pharmaceutical company developing clinical programs including treatments for Fragile X Syndrome.

BiotechHealthtechFlorham Park, US

Co-investorsInvest Michigan

Therini Biotherinibio.cominApr 2023 · $39M

Therini Bio is a biotechnology company developing fibrin-targeting therapeutics to treat neurological and ophthalmological diseases, leveraging scientific discoveries in neurovascular and neuroimmune mechanisms of disease.

BiotechDigital HealthHealthtechMedical DevicesSacramento, US

Katerina Akassoglou(Scientific Founder, Director of the Center for Neurovascular Brain Immunology and Professor of Neurology at UCSF and Gladstone Institutes)inKaterina Akassoglou, PhD(Scientific Founder)Leslie Schulze(Executive Officer)Tara Nickerson(Executive Officer, Director)in

BoardOlga Danilchanka(Director)inLaia Crespo-Martin(Director)

Co-investorsMRL Ventures FundSanofi VenturesSV Health InvestorsAngelini VenturesDementia Discovery FundMitsui Global Investment+2 more

Transition Biotransitionbio.com

Transition Bio applies methods from physics, chemistry, biology, and machine learning to study protein biophysics—including protein aggregation, self-assembly, and protein-protein interactions—for developing therapeutics targeting health and disease.

AI & Machine LearningBiotechDeep TechCambridge, US

Tuomas Knowles(Executive Director, Co-Founder & Chief Technology Officer)Samuel Cohen(Executive Director & Co-Founder)inG. Kelly Martin(Executive Chairman & Co-Founder)George Martin(Executive Officer, Director)inStephanie Torruella(Executive Officer)inPreet Makkar(Executive Officer)

Co-investorsNorthpond VenturesLifeforce CapitalMagnetic VenturesTaiho Ventures, LLC

Transition Metal Solutionstransition.bio

Transition Bio develops custom chemical additives that stimulate naturally occurring microbes to extract copper from low-grade primary and secondary sulfide ores during heap and dump leaching, improving recovery while reducing acid, water, and energy use.

BiotechCleantechNew Materials

Alexandra Shiluk(Co-founder and COO)inSasha Milshteyn(Founder & CEO)in

Co-investorsSOSV

Transitionmetaltransitionmetal.comin

Transition Metal Solutions applies microbial and biochemical methods to enhance copper extraction from low-grade ores, enabling more efficient recovery with reduced environmental impact for mining operations.

BiotechCleantechNew Materials

Co-investorsJuniperNew Climate VenturesIndieBioPossible Ventures

TripleBlindtripleblind.aiSeed · Oct 2021 · $24M

TripleBlind develops privacy and security software using quantum-safe and cryptographic methods, with two main products: Privacy Suite for HIPAA-compliant sharing of protected health data and SecuriKey, a software-only security module addressing account takeover attacks.

CybersecurityDigital HealthSaaSKansas City, US

Riddhiman Das(Executive Officer, Director)Greg Storm(Executive Officer, Director)inAndrew Krowne(Director)in

BoardThad Langford(Director)in

Co-investorsAlumni VenturesClocktower VenturesFlyover CapitalKCRise FundRolling Fun GPAccenture Ventures+5 more

Ubotica Technologiesubotica.com

Ubotica builds orbital AI that runs across satellites and ground systems to monitor the maritime domain, predicting where risk is rising, tasking satellites and sensors to investigate, and delivering actionable intelligence.

AI & Machine LearningDefense TechSpace Tech

Co-investorsAct Venture CapitalACT Venture CapitalAtlantic Bridge VenturesGreencode VenturesSeraphim Space

Ursa Majorursamajor.comin𝕏

Ursa Major develops flight-proven aerospace and defense systems, including hypersonic engines, solid rocket motors, and space mobility solutions for military and defense applications.

Defense TechHardwareSpace TechBerthoud, US

Joe Laurienti(Founder)inNick Doucette(Co-Founder & Vice President, Strategic Operations)inDan Jablonsky(CEO)inChris Spagnoletti(Chief Executive Officer)in

Co-investorsAlpha EdisonAtento CapitalBalerion Space VenturesBrave CapitalCrosscourt VenturesEclipse Ventures+10 more

Ursa Major Technologiesursamajortechnologies.cominDec 2021 · $85M

Colorado aerospace and defense manufacturer of rocket engines, solid rocket motors, hypersonic and in-space propulsion systems.

Berthoud, US

Joseph A. Laurienti, Jr.(Executive Officer, Director, Promoter)Nicholas Doucette(Executive Officer)David Gregory(Executive Officer)

BoardStewart Alsop(Director)in

Co-investorsAlsop Louie PartnersAlumni VenturesRTX VenturesAlpha EdisonBlackRockEclipse+3 more

Vorticityvorticity.xyzinSeries A

Vorticity is building a scientific computing platform, redesigned from processor architecture up through system design, to run large-scale physics and engineering simulations faster.

Advanced ManufacturingDeep TechHardwareRoboticsSemiconductorsSan Francisco, US

Chirath Neranjena(Founder)in

Co-investorsAlumni VenturesCambium CapitalY CombinatorAcequia Capital (AceCap)

Wickrwickr.com𝕏Acquired

AWS Wickr is an enterprise-grade secure communication platform offering end-to-end encrypted messaging, voice, and video collaboration for organizations handling sensitive information, with compliance certifications including FedRAMP High and DoD IL4/5.

CybersecurityEnterprise SoftwareSaaSChicago, US

Christopher Howell(Executive Officer)inJennifer DeTrani(Executive Officer)Nico Sell(Co-Founder & Chairman)Kara Coppa(Executive Officer)Braden Seely(Executive Officer)York Sell(Executive Officer)

Co-investorsAlsop Louie PartnersBreyer CapitalGen CapitalHacker.Capital LLCIronGate Capital AdvisorsLytical Ventures+1 more

Yumanity Therapeuticsyumanity.com

Neurodegenerative disease drug discovery correcting misfolded-protein cellular pathologies.

ConsumerHealthtechMedia & EntertainmentBoston, US

N. Anthony Coles(Executive Officer, Director)Richard Peters(Executive Officer, Director)Paulash Mohsen(Executive Officer)Brigitte Robertson(Executive Officer)Richard A. Heyman(Director)inJeffery W. Kelly(Director)

Co-investorsAltium CapitalPfizer Venture InvestmentsSanofi VenturesAlexandriaFidelity InvestmentsREDMILE

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

AltSpaceVRArclight TherapeuticsAtomos Nuclear and Space CorporationAtomwise (now named Numerion Labs)AZTherapiesBasis ScienceBeep NetworksChirp MicrosystemEntasis TherapeuticsEt CereEyefluenceGladstonegoBaltoM3 BiotechnologyMixed DimensionsNativewavesPlethoraSalkSharrow EngineeringSoundThinkingSource EnergyStanfordpmhwTetra Discovery PartnersUclViumZebra Medical Vision

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.